-
- Academic Editors
-
-
-
Background: Intramyocardial hemorrhage (IMH) is a result of
ischemia-reperfusion injury in ST-segment elevation myocardial infarction (STEMI)
after primary percutaneous coronary intervention (PPCI). Despite patients with
IMH show poorer prognoses, studies investigating predictors of IMH occurrence are
scarce. This study firstly investigated the effectiveness of regulatory T cell
(Treg), peak value of Creatine Kinase MB (pCKMB), high-sensitivity C-reactive
protein (hsCRP), and left ventricular end-systolic diameter (LVESD) as predictors
for IMH. Methods: In 182 STEMI patients received PPCI, predictors of IMH
were analyzed by logistic regression analysis. The predictive
ability of risk factors for IMH were determined by receiver operating
characteristic curves, net reclassification improvement (NRI), integrated
discrimination improvement (IDI) and C-index. Results: Overall, 80
patients (44.0%) developed IMH. All 4 biomarkers were independent predictors of
IMH [odds ratio [OR] (95% confidence interval [CI]): 0.350 (0.202–0.606) for Treg, 1.004 (1.001–1.006) for pCKMB, 1.060 (1.022–1.100) for hsCRP, and 3.329 (1.346–8.236) for LVESD]. After
propensity score matching (PSM), the biomarkers significantly predicted IMH with
areas under the curve of 0.750 for Treg, 0.721 for pCKMB, 0.656 for hsCRP, 0.633
for LVESD, and 0.821 for the integrated 4-marker panel. The addition of
integrated 4-marker panel to a baseline risk model had an incremental effect on
the predictive value for IMH [NRI: 0.197 (0.039 to 0.356); IDI: 0.200 (0.142 to
0.259); C-index: 0.806 (0.744 to 0.869), all p